MarketCap
Facebook
X
Telegram
Intuitive Surgical Net Debt | ISRG
Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]
Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.
Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.
Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.
Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.
Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.
Annual Net Debt Intuitive Surgical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.2 B | -1.88 B | -2.66 B | -1.49 B | -1.22 B | - | -1.17 B | -858 M | -648 M | -1.04 B | -715 M | -600 M | -782 M | -554 M | -466 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -466 M | -3.2 B | -1.23 B |
References
- Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.
Net Debt of other stocks in the Medical instruments industry
| Issuer | Net Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AtriCure
ATRC
|
-104 M | $ 35.04 | 6.18 % | $ 1.67 B |  USA |
 |
Atrion Corporation
ATRI
|
-45 M | - | - | $ 810 M | USA |
 |
Luminex Corporation
LMNX
|
-106 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
-517 K | - | -9.52 % | $ 20.6 M | USA |
 |
BioLife Solutions
BLFS
|
-85.1 M | $ 29.98 | -2.57 % | $ 1.43 B | USA |
 |
CRH Medical Corporation
CRHM
|
66.8 M | - | - | $ 282 M | USA |
 |
ResMed
RMD
|
-521 M | $ 195.27 | 1.76 % | $ 28.6 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
-12.2 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
781 M | - | -1.18 % | $ 3.4 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.58 B | - | -0.05 % | $ 10.3 B | USA |
 |
STAAR Surgical Company
STAA
|
-115 M | $ 23.38 | -3.35 % | $ 1.16 B | USA |
 |
STERIS plc
STE
|
1.41 B | $ 214.07 | 1.64 % | $ 21 B | USA |
 |
Teleflex Incorporated
TFX
|
2.26 B | $ 132.1 | 0.69 % | $ 5.89 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-581 K | - | - | $ 28.6 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
-411 M | - | -0.02 % | $ 16.3 B | USA |
 |
Nephros
NEPH
|
-5 M | $ 3.64 | -3.45 % | $ 38.6 M | USA |
 |
West Pharmaceutical Services
WST
|
-566 M | $ 328.2 | -7.67 % | $ 23.7 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.74 B | $ 12.93 | 1.65 % | $ 2.58 B | USA |
 |
Isoray
ISR
|
-28.4 M | - | 0.03 % | $ 108 M | USA |
 |
electroCore
ECOR
|
-53 K | $ 6.19 | -2.75 % | $ 52.5 K | USA |
 |
Haemonetics Corporation
HAE
|
983 M | $ 78.78 | 1.78 % | $ 3.72 B | USA |
 |
Predictive Oncology
POAI
|
-9.23 M | - | - | $ 31.1 M | USA |
 |
The Cooper Companies
COO
|
2.38 B | $ 70.31 | 0.11 % | $ 14 B | USA |
 |
AngioDynamics
ANGO
|
-47.2 M | $ 13.59 | 1.12 % | $ 564 M | USA |
 |
NeuroMetrix
NURO
|
-1.49 M | - | 5.05 % | $ 9.02 M | USA |
 |
Pulse Biosciences
PLSE
|
-73.2 M | $ 30.23 | -2.48 % | $ 2.04 B | USA |
 |
iRhythm Technologies
IRTC
|
-154 M | $ 109.2 | 1.42 % | $ 3.49 B | USA |
 |
Repligen Corporation
RGEN
|
-2.25 M | $ 131.96 | -4.1 % | $ 7.42 M | USA |
 |
Pro-Dex
PDEX
|
15 M | $ 54.93 | 0.48 % | $ 181 M | USA |
 |
Merit Medical Systems
MMSI
|
299 M | $ 74.32 | 1.66 % | $ 4.4 B | USA |
 |
InfuSystem Holdings
INFU
|
16.4 M | $ 9.12 | 2.59 % | $ 188 M | USA |
 |
Glaukos Corporation
GKOS
|
-21.4 M | $ 153.58 | 0.95 % | $ 8.78 B | USA |
 |
Baxter International
BAX
|
7.55 B | $ 22.4 | 3.37 % | $ 11.5 B | USA |
 |
Harvard Bioscience
HBIO
|
28.8 M | $ 6.0 | -3.56 % | $ 266 M | USA |
 |
ICU Medical
ICUI
|
972 M | $ 157.44 | 2.59 % | $ 3.88 B | USA |
 |
Alcon
ALC
|
2.46 B | $ 67.91 | 1.04 % | $ 40.4 B |  Schweiz |
 |
Stereotaxis
STXS
|
-7.98 M | $ 1.29 | -8.51 % | $ 117 M | USA |
 |
Milestone Scientific
MLSS
|
-955 K | $ 0.39 | -2.94 % | $ 32 M | USA |
 |
Envista Holdings Corporation
NVST
|
276 M | $ 26.33 | 0.61 % | $ 4.42 B | USA |
 |
Masimo Corporation
MASI
|
572 M | - | - | $ 9.59 B | USA |
 |
Microbot Medical
MBOT
|
-3.05 M | $ 1.71 | -2.84 % | $ 78.3 M |  Israel |
 |
Repro Med Systems
KRMD
|
-8.38 M | $ 3.83 | 2.68 % | $ 177 M | USA |
 |
OraSure Technologies
OSUR
|
-197 M | $ 3.97 | -1.49 % | $ 292 M | USA |
 |
LeMaitre Vascular
LMAT
|
143 M | $ 95.59 | -1.95 % | $ 2.16 B | USA |
 |
Becton, Dickinson and Company
BDX
|
17.1 B | $ 156.36 | 2.22 % | $ 45 B | USA |
 |
Retractable Technologies
RVP
|
-1.69 M | $ 0.68 | - | $ 20.4 M | USA |
 |
Utah Medical Products
UTMD
|
-60.6 M | $ 67.14 | 4.61 % | $ 218 M | USA |